An Open-label Study to Evaluate the Long-term Safety and Tolerability of LUM001 in Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary CirrhosisIntervention: Drug: LUM001Sponsor: Lumena Pharmaceuticals, Inc.Not yet recruiting - verified March 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials